Biosynex SA (ALBIO.PA)

EUR 1.35

(-12.65%)

Long Term Debt Summary of Biosynex SA

Biosynex SA's latest annual long term debt in 2023 was 59.57 Million EUR , up 33.65% from previous year.
Biosynex SA's latest quarterly long term debt in 2023 FY was 59.57 Million EUR , up 33.65% from previous quarter.
Biosynex SA reported annual long term debt of 44.57 Million EUR in 2022, up 55.77% from previous year.
Biosynex SA reported annual long term debt of 28.61 Million EUR in 2021, up 193.39% from previous year.
Biosynex SA reported quarterly long term debt of 15.52 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Biosynex SA reported quarterly long term debt of 59.57 Million EUR for 2023 FY, up 33.65% from previous quarter.

Annual Long Term Debt Chart of Biosynex SA (2023 - 2009)

Historical Annual Long Term Debt of Biosynex SA (2023 - 2009)

Year	Long Term Debt	Long Term Debt Growth
2023	59.57 Million EUR	33.65%
2022	44.57 Million EUR	55.77%
2021	28.61 Million EUR	193.39%
2020	9.75 Million EUR	18.67%
2019	8.21 Million EUR	66.29%
2018	4.94 Million EUR	-14.54%
2017	5.78 Million EUR	1.69%
2016	5.68 Million EUR	79.49%
2015	3.16 Million EUR	95.15%
2014	1.62 Million EUR	0.36%
2013	1.61 Million EUR	-20.72%
2012	2.04 Million EUR	427.59%
2011	386.74 Thousand EUR	18.2%
2010	327.21 Thousand EUR	-9.59%
2009	361.91 Thousand EUR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2023 Q4	59.57 Million EUR	0.0%
2023 Q2	15.52 Million EUR	0.0%
2023 FY	59.57 Million EUR	33.65%
2022 Q4	44.57 Million EUR	0.0%
2022 FY	44.57 Million EUR	55.77%
2022 Q2	29.63 Million EUR	0.0%
2021 Q4	28.61 Million EUR	0.0%
2021 Q2	16.44 Million EUR	0.0%
2021 FY	28.61 Million EUR	193.39%
2020 Q2	10.69 Million EUR	0.0%
2020 Q4	9.75 Million EUR	0.0%
2020 FY	9.75 Million EUR	18.67%
2019 Q2	3.24 Million EUR	0.0%
2019 FY	8.21 Million EUR	66.29%
2019 Q4	8.21 Million EUR	0.0%
2018 Q4	4.94 Million EUR	0.0%
2018 FY	4.94 Million EUR	-14.54%
2018 Q2	4.17 Million EUR	0.0%
2017 FY	5.78 Million EUR	1.69%
2017 Q2	4.34 Million EUR	0.0%
2017 Q4	5.78 Million EUR	0.0%
2016 FY	5.68 Million EUR	79.49%
2016 Q2	906 Thousand EUR	0.0%
2016 Q4	5.68 Million EUR	0.0%
2015 Q2	1.21 Million EUR	0.0%
2015 FY	3.16 Million EUR	95.15%
2015 Q4	3.16 Million EUR	0.0%
2014 Q4	1.62 Million EUR	0.0%
2014 FY	1.62 Million EUR	0.36%
2014 Q2	1.4 Million EUR	0.0%
2013 Q2	1.82 Million EUR	0.0%
2013 FY	1.61 Million EUR	-20.72%
2013 Q4	1.61 Million EUR	0.0%
2012 Q4	2.04 Million EUR	0.0%
2012 Q2	2.76 Million EUR	0.0%
2012 FY	2.04 Million EUR	427.59%
2011 FY	386.74 Thousand EUR	18.2%
2011 Q4	386.74 Thousand EUR	0.0%
2011 Q2	309.6 Thousand EUR	0.0%
2010 FY	327.21 Thousand EUR	-9.59%
2010 Q4	327.21 Thousand EUR	0.0%
2009 FY	361.91 Thousand EUR	0.0%

Peer Long Term Debt Comparison of Biosynex SA

Name	Long Term Debt	Long Term Debt Difference
Predilife S.A.	7.35 Million EUR	-709.596%
bioMérieux S.A.	355.4 Million EUR	83.237%
Eurofins Scientific SE	3.88 Billion EUR	98.468%
Lumibird SA	121.56 Million EUR	50.994%